Ad Sensor-based Real-time Diagnosis of Adenovirus

Status Recruiting

Clinical Trial Summary

To develop a real-time diagnostic technique with Ad sensor for Adenovirus detection, the investigators conduct a prospective clinical study. In comparison with results from direct sequencing of Adenovirus, the investigators evaluate the performance of Ad sensor , including reproducibility, sensitivity, specificity, and cross-reaction. The potential factors which may interfere with the results would be investigated. With such technique, the investigators hope to make early diagnosis and give Adenovirus patients early treatment to reduce the complications and case-fatality rate.

Clinical Trial Description

1. Sample acquirement： At National Taiwan University Hospital in Taiwan, we will enroll patients who have Adenovirus infection . We will take three throat swabs for each patient: one for viral isolation, one for RT-PCR and the last for the Ad sensor - based real-time diagnosis.

2. Ad sensor diagnosis： Ad sensor (structural chip-based optosensing virus probing system), which is for the rapid and sensitive detection of viral antigen in medical samples, will be used for analyzing the interaction kinetics between anti-Adenovirus and its Adenovirus antigen present in patients'and normal samples.

3. Gold standard： viral isolation and RT-PCR ;

Study Design

Intervention Model: Single Group Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02008812
Study type	Interventional
Source	National Taiwan University Hospital
Contact	Shiming Lin, PhD
Phone	886-2-23123456
Email	til@ntu.edu.tw
Status	Recruiting
Phase	N/A
Start date	August 2011
Completion date	December 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02984280` - Specific Respiratory Infections as Triggers of Acute Medical Events	N/A
Recruiting	`NCT03665675` - Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT	Early Phase 1
Completed	`NCT01431326` - Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Recruiting	`NCT03266627` - Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection	Phase 2
Not yet recruiting	`NCT03325517` - Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics	N/A
Not yet recruiting	`NCT06392451` - LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia	N/A
Recruiting	`NCT05183490` - R-MVST Cells for Treatment of Viral Infections	Phase 1
Completed	`NCT04056546` - Interest of Rapid Typing in Adenovirus Infections.
Withdrawn	`NCT00448994` - Adenovirus and Fungal Load in Pediatric Stem Cell Transplant Patients	N/A
Recruiting	`NCT06299813` - Effectiveness of a Single Dose of Betamethasone in Children With Symptomatic Adenovirus Infection	Phase 3
Enrolling by invitation	`NCT06027879` - Anti-viral T-cell Therapy by Gamma Capture	Phase 1/Phase 2
Recruiting	`NCT02779439` - Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation	Phase 1
Terminated	`NCT02420080` - A Multicenter Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection to Serve as Matched Historical Controls for Study CMX001-304	N/A
Active, not recruiting	`NCT01945814` - Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL)	Phase 1
Completed	`NCT01535885` - Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV, and CMV	Phase 1
Terminated	`NCT03339401` - The AdAPT Trial; Adenovirus After Allogeneic Pediatric Transplantation	Phase 2
Withdrawn	`NCT01584037` - Adenovirus Vaccine Pregnancy Registry	N/A
Withdrawn	`NCT03532035` - Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus Viremia	Phase 2
Active, not recruiting	`NCT04364178` - Viral Specific T-Lymphocytes to Treat Adenovirus or CMV	Phase 1/Phase 2
Recruiting	`NCT05664126` - Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation	Phase 2